Identification of expressed genes characterizing long-term survival in malignant glioma patients

Oncogene

Volumn 25, Issue 44, 2006, Pages 5994-6002

  Yamanaka, R ^a   Arao, T ^b   Yajima, N ^a   Tsuchiya, N ^a   Homma, J ^a   Tanaka, R ^a   Sano, M ^a   Oide, A ^c   Sekijima, M ^c   Nishio, K ^b  

^a NIIGATA UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c MITSUBISHI CHEMICAL CORPORATION   (Japan)

Author keywords

cDNA array; Gene expression profiles; Glioma; siRNA; Survival predictor

Indexed keywords

DISCOIDIN DOMAIN RECEPTOR FAMILY MEMBER 1 PROTEIN; DUAL SPECIFICITY TYROSINE PHOSPHORYLATION REGULATED KINASE 3; MESSENGER RNA; PROTEIN; PROTEIN KSP37; RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER PATIENT; CANCER SURVIVAL; CELL INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; MULTIVARIATE ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA SYNTHESIS; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION PROFILING; GLIOMA; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 33749189559     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209585     Document Type: Article

References (34)

1. Agrawal D, Chen T, Irby R, Quackenbush J, Chambers AF, Szabo M et al. (2002). J Natl Cancer Inst 94: 513-521.
2. Freije WA, Castro-Vargas FE, Fang Z, Horvath S, Cloughesy T, Liau LM et al. (2004). Cancer Res 64: 6503-6510.
3. Godard S, Getz G, Delorenzi M, Farmer P, Kobayashi H, Desbaillets I et al. (2003). Cancer Res 63: 6613-6625.
4. Hoelzinger DB, Mariani L, Weis J, Woyke T, Berens TJ, McDonough WS et al. (2005). Neoplasia 7: 7-16.
5. Hunter SB, Brat DJ, Olson JJ, Von Deimling A, Zhou W, Van Meir EG. (2003). Int J Oncol 23: 857-869.
6. Karpeh MS, Kelsen DP, Tepper JE. (2001) In: Devita Jr VT (ed) Cancer of the Stomach: Cancer, Principles & Practice of Oncology, 6th edn. Lippincott Williams & Wilkins: Philadelphia, pp 1092-1121.
7. Khan J, Wei JS, Ringner M, Saal LH, Ladanyi M, Westermann F et al. (2001). Nat Med 7: 673-679.
8. Kim S, Dougherty ER, Shmulevich I, Hess KR, Hamilton SR, Trent JM et al. (2002). Mol Cancer Ther 1: 1229-1236.
9. Kleihues P, Cavenee WK. (2000). World Health Organization Classification of Tumours of the Nervous System. WHO/IARC: Lyon, France.
10. Li K, Zhao S, Karur V, Wojchowski DM. (2002). J Biol Chem 277: 47052-47060.
11. Liang Y, Diehn M, Watson N, Bollen AW, Aldape KD, Nicholas MK et al. (2005). Proc Natl Acad Sci USA 102: 5814-5819.
12. Mischel PS, Cloughesy TF, Nelson SF. (2004). Nat Rev Neurosci 5: 782-792.
13. Mischel PS, Shai R, Shi T, Horvath S, Lu KV, Choe G et al. (2003). Oncogene 22: 2361-2373.
14. Nigro JM, Misra A, Zhang L, Smirnov I, Colman H, Griffin C et al. (2005). Cancer Res 65: 1678-1686.
15. Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C et al. (2003). Cancer Res 63: 1602-1607.
16. Ogawa K, Tanaka K, Ishii A, Nakamura Y, Kondo S, Sugamura K et al. (2001). J Immunol 166: 6404-6412.
17. Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, Angelo M et al. (2001). Proc Natl Acad Sci USA 98: 15149-15154.
18. Ram R, Lorente G, Nikolich K, Urfer R, Foehr E, Nagavarapu U. (2006). J Neurooncol 76: 239-248.
19. Rickman DS, Bobek MP, Misek DE, Kuick R, Blaivas M, Kurnit DM et al. (2001). Cancer Res 61: 6885-6891.
20. Rich JN, Hans C, Jones B, Iversen ES, McLendon RE, Rasheed BK et al. (2005). Cancer Res 65: 4051-4058.
21. Sallinen SL, Sallinen PK, Haapasalo HK, Helin HJ, Helen PT, Schraml P et al. (2000). Cancer Res 60: 6617-6622.
22. Shai R, Shi T, Kremen TJ, Horvath S, Liau LM, Cloughesy TF et al. (2003). Oncogene 22: 4918-4923.
23. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A et al. (2003). Proc Natl Acad Sci USA 100: 8418-8423.
24. Somasundaram K, Reddy SP, Vinnakota K, Britto R, Subbarayan M, Nambiar S et al. (2005). Oncogene 24: 7073-7083.
25. Stewart LA. (2002). Lancet 359: 1011-1018.
26. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al. (2005). N Engl J Med 352: 987-996.
27. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW et al. (2002). N Engl J Med 347: 1999-2009.
28. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M et al. (2002). Nature 415: 530-536.
29. van den Boom J, Wolter M, Kuick R, Misek DE, Youkilis AS, Wechsler DS et al. (2003). Am J Pathol 163: 1033-1043.
30. Vogel W. (1999). FASEB J 13: S77-82.
31. Vogel W, Brakebusch C, Fassler R, Alves F, Ruggiero F, Pawson T. (2000). J Biol Chem 275: 5779-5784.
32. Weiner HL, Zagzag D. (2000). Cancer Invest 18: 544-554.
33. Wong KK, Chang YM, Tsang YT, Perlaky L, Su J, Adesina A et al. (2005). Cancer Res 65: 76-84.
34. Yoshimura T, Matsuyama W, Kamohara H. (2005). Immunol Res 31: 219-230.